Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asthma control with salmeterol/fluticasone Diskus in steroid-naive or low-dose ICS patients
2006-000253-21Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of salmeterol + fluticasone, salmeterol and fluticasone propionate in asthma, sponsored by GSK. Primary endpoint: Good asthma control by GOAL criteria and ACT response. Started Mar 2006; status: completed.
02
Drugs
salmeterol + fluticasonesalmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000253-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000253-21.